1014.2000 -14.60 (-1.42%)
NSE Jun 13, 2025 15:31 PM
Volume: 79,030
 

1014.20
-1.42%
BOB Capital Markets Ltd.
Strong Q1 with EBITDA/PAT beat of 10%/6% despite slight miss on revenue
Alivus Life Sciences Ltd. is trading below all available SMAs
More from Alivus Life Sciences Ltd.
Recommended